BioCentury
ARTICLE | Company News

XTL board of directors update

August 18, 2008 7:00 AM UTC

XTL Biopharmaceuticals Ltd. (NASDAQ:XTLB; Tel Aviv:XTL), New York, N.Y. Business: Infectious, Antibodies Appointed: Samuel Rudman, a partner at Coughlin Stoia Geller Rudman & Robbins LLP ...